Free EHR, EHR and Healthcare IT Newsletter Want to receive the latest updates on EHR, EMR and Healthcare IT news sent straight to your email? Get all the latest EHR News for FREE!

Hg Invests in Orion Health Rhapsody and Population Health Businesses

BOSTON, Massachusetts – 6 July 2018 – Orion Health Group Limited (NZX:OHE/ASX:OHE) announced that it has reached an agreement in relation to Orion Health’s Rhapsody and Population Health businesses with Hg, a specialist technology investor committed to helping build global businesses with funds of c.£10 billion under management.

The agreement is for entities managed by Hg to acquire majority ownership of Orion Health’s Rhapsody business and to invest in Orion Health’s Population Health business.

Healthcare technology is a core investment area for Hg, having recently completed a number of transactions across the sector. This investment will be made from Hg’s Mercury 2 Fund.

Orion Health built the first Rhapsody integration engine in the late-1990s quickly becoming one of the most recognized interoperability platforms for healthcare organizations today. The combination of Rhapsody’s global team and Hg’s resources will extend Rhapsody as a leader in the interoperability platform space, building on both Rhapsody’s world class technology and highly rated customer service.

Philippe Houssiau, an experienced global technology executive, will step in to lead the Rhapsody business. Philippe has broad experience in leading healthcare businesses, consulting and start-ups, and is formerly CEO of Agfa Healthcare, CEO of Alliance Medical and a Senior Partner with PwC.

“This investment provides Orion Health with a tremendous opportunity to deliver on our vision for customers, our people and for the healthcare sector,” said Ian McCrae, Founder and CEO, Orion Health. “The Board and I believe that Hg is the right partner to accelerate the expansion of Rhapsody and support our vision for our Population Health business.”

“Hg has been researching the theme of interoperability and population health management in healthcare IT over many years,” said David Issott, Partner, Hg. “We believe this is a key global growth theme backed by substantial market funding and resources. Rhapsody provides fantastic products and services for this market and we look forward to partnering with the team at Rhapsody to maximize its potential across the globe. We are also excited to work with Ian and the team to realize the full potential of the Population Health business.”

“Rhapsody is a high-quality business with strong underlying fundamentals and a solid pipeline of new business,” said Philippe Houssiau, CEO Rhapsody. “We believe that the current healthcare market dynamic, with increasing requirement for ‘data liquidity’, presents Rhapsody with a real opportunity for further growth and a solid base for sustained performance. With a focused leadership team and the investment provided by Hg, Rhapsody will be able to leverage its core markets whilst expanding into selected and emerging segments.”

Full details of the transaction can be found in a Market Release on the investor page of Orion Health’s website here. Summary:

–          Hg will acquire Rhapsody for NZ$205 million funded by debt and equity arranged by Hg. Orion Health will then utilize circa NZ$28 million of the transaction proceeds to acquire an ongoing 24.9% shareholding in the Rhapsody business.

–          Hg will also acquire a 24.9% stake in Population Health by investing circa NZ$20 million in that business. Orion Health will invest around NZ$12 million of the Rhapsody transaction proceeds in Population Health based on an agreed enterprise value of NZ$50 million (on a cash free and debt free basis) together with NZ$30 million of net cash to fund ongoing operations.

–          Orion Health will continue to own 100% of its Hospitals business.

–          Following completion of the Hg Transaction, Orion Health will undertake a share buyback offer at an estimated price range of $1.24-$1.29 per share, with the final offer price dependent on Orion Health’s available cash immediately following completion taking into account transaction costs and working capital adjustments in relation to the Rhapsody transaction. Shareholders will have the option to accept the share buyback offer in respect of all or a specified proportion of their Orion Health shares.

–          The bottom of the estimated buy back price range represents a premium of 46% to the closing price per Orion Health share of $0.85 on 2 July 2018 and 55% to the volume weighted average trading price over the last 20 trading days.

The injection of capital will provide investment for Orion Health to build leading global technology for the healthcare sector.

“As the healthcare sector evolves, so too has Orion Health. We believe the biggest advances in healthcare technology will come from a range of capabilities including advanced analytics and better data flow to address critical issues within the sector. In the face of growing and aging populations and the rise of chronic diseases, health systems the world over are under enormous strain. Our Population Health and Hospitals solutions are focused on helping healthcare organizations turn data into insights and clinical action and allow them to use this knowledge to optimize budgets and provide targeted patient care.

“This injection of capital will advance Orion Health’s businesses to reach their full potential over time. For our Population Health business, it will help strengthen our position as a market leader, and for our Hospitals business, it will further support its growth,” said McCrae.

The transaction is subject to a number of conditions, including regulatory approval and the share buyback offer by Orion Health’s shareholders. A notice of meeting describing the Hg Transaction and the share buyback offer will be circulated to shareholders. The independent directors have also commissioned an independent report from KordaMentha.

“This transaction is an important stepping stone in Orion Health’s efforts to build a solid and competitive business and provides our shareholders with choice in relation to their investment,” said Andrew Ferrier, Chairman of the Board, Orion Health. “We believe that providing shareholders both the option to cash-out at a substantial premium to the current trading price and the opportunity to elect to maintain an ongoing investment in Orion Health, including its 24.9% stake in Rhapsody and 75.1% stake in Population Health, is in the best interests of shareholders. This transaction has strong support from Orion Health’s Board and major shareholders.”

About Orion Health
Orion Health (NZX:OHE/ASX:OHE) is a health technology company that provides solutions which enable healthcare to over 110 million patients globally. Its open technology platform, Orion Health Amadeus, seamlessly integrates all forms of relevant data to enable population and personalized healthcare around the world. The company is committed to continual innovation to cement its position at the forefront of precision medicine. For more information visit www.orionhealth.com.

About Hg
Hg is a sector expert investor, committed to helping build ambitious businesses across the technology, services and industrial technology space, primarily in Europe. Deeply resourced sector teams focus on specific sub-sectors and investment themes to identify companies occupying an established position within a niche, and which have the potential to grow faster than their market, create employment and become the leader in their industry. Hg’s dedicated operations innovation team provides practical support to management teams to help them realise their growth ambitions. Based in London and Munich, Hg has funds under management of c. £10 billion serving some of the world’s leading institutional and private investors. For further details, please see www.hgcapital.com

July 9, 2018 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Inspirata Acquires Health Analytics Company, Caradigm; Plans to Use its Award-Winning Platform to Accelerate Development of its Cancer Information Data Trust

Inspirata will continue to evolve Caradigm’s population health management solutions and support existing customers, and has aggressive plans to create new customers in this space.

Redmond, WA, June 13, 2018 (GLOBE NEWSWIRE) — Cancer informatics and digital pathology workflow solution provider Inspirata®, Inc. announced today that it has acquired Redmond, WA-based Caradigm from GE Healthcare.

The company’s award-winning Caradigm Intelligence Platform (CIP) and population health management software portfolio spans data control; healthcare analytics; and care coordination and engagement across the entire healthcare enterprise, including large integrated delivery networks, accountable care organizations, clinically integrated networks, academic medical centers and community hospital networks.

“Caradigm has built a highly regarded, industry-proven big data health analytics platform,” says Inspirata CEO Satish Sanan. “Our goal is to leverage the core strengths of this platform to accelerate our Cancer Information Data Trust (CIDT) development. The CIDT will address key trends in oncology care providing important new insights for clinicians, researchers, drug discovery and cancer center operations. In addition to this, Caradigm’s strong population health product set and experienced team will have Inspirata’s specialized focus and attention to promote long-term sustainability, growth and innovation as we redouble our focus on delivering superior value to all customers.”

“We are confident that Inspirata will be able to provide the intense focus and vision needed for growth through key investments in technology, infrastructure and people to energize the Caradigm software portfolio to better enable us to serve customers’ evolving needs,” says Caradigm President and CEO Neal Singh. “The healthcare ecosystem is in dire need of change. With Inspirata, Caradigm can bring that change for providers and advance the health of the patients they serve.”

Caradigm provides an open and a flexible platform that builds a data foundation to meet the evolving demands of a dynamic healthcare environment. Caradigm Intelligence Platform aggregates data across clinical, social, operational and financial sources from disparate source systems – electronic health records, billing systems, payers, claims, pharmacy systems, labs and HIEs, coupled with the need for timely information at the point of care to address a longstanding challenge for healthcare organizations. Caradigm also provides a suite of applications for improving the patient experience of care, improving the health of populations and reducing the per capita cost of healthcare. Caradigm population health solutions enable providers to deliver the appropriate care to patients through effective coordination and patient engagement, improving outcomes and financial results.

About Inspirata, Inc.

Inspirata®, Inc. provides oncology diagnostics workflow solutions that span digital pathology; diagnostic and predictive assays; and precision medicine. It also offers cancer informatics workflows that, in combination with its natural language processing and artificial intelligence algorithms structures unstructured case files and clinician notes to provide key insights for clinical and operational activities as well as cancer reporting. Inspirata’s flagship solution is its Cancer Information Data Trust (CIDT) that generates a longitudinal view of oncology patients—from diagnosis, through treatments and therapies, to outcomes. The CIDT has extensive applications in clinical decision support, research, education, drug discovery and clinical trials enrollment. Its use will extend to physicians, patients, researchers, pharma and others. For more information, please visit www.inspirata.com or contact info@inspirata.com.

About Caradigm

Until its acquisition by Inspirata today, Caradigm was a GE Healthcare Company offering intelligent healthcare analytics and population health management solutions. Caradigm is dedicated to improving patient care, advancing the health of populations and reducing healthcare costs. Its enterprise software portfolio encompasses all capabilities critical to delivering effective population health management, including data control; healthcare analytics; and care coordination and engagement. Caradigm’s customers include large integrated delivery networks, accountable care organizations, clinically integrated networks, academic medical centers, and community hospital networks. Based in Redmond, WA, Caradigm received the Frost & Sullivan 2017 North American Health IT Value-Based Care Management Product Leadership Award. For more information, visit our website.

June 13, 2018 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

BaseHealth Raises $8.5 Million in Series C Funding

Company uses predictive analytics to uncover rising risk patients within a population

Sunnyvale, California: Oct. 18, 2017 – BaseHealth, the creator of the first predictive, evidence-based, and data-driven population health management solution, today announced that it has received an overall investment of $8.5 million, including $2.5 million from lead investor HBM Healthcare Investments (SIX HBMN), a listed healthcare investment company with net assets over $1 billion.

The investment will be used to further develop BaseHealth’s analytics engine, which is based on peer-reviewed medical literature, curated by physicians and scientists, and enhanced with laboratory, biometric, social, family history and behavioral data. BaseHealth supplements this with retrospective claims and ICD data. The data is then passed through the analytics engine, which uses machine learning and artificial intelligence (AI) to assess patient risk for 43 possible disease threats.

BaseHealth’s approach to population health and value-based care enables healthcare professionals to improve care and reduce the per capita cost of healthcare by identifying the rising unknown risk within their patient population, so they can intervene to both prevent diseases before they start and control them before it’s too late. The “Invisible Patient” is how BaseHealth refers to these individuals. With the right medical intervention at the right time, their healthcare trajectory can be improved.

“Healthcare systems have a lot of data and yet they still have a hard time finding these patients, making it hard to respond proactively to patient care needs,” said Jason Pyle, CEO, BaseHealth. “Our system enables healthcare professionals to assess the unknown risk that exists within their patient population and provide access and critical care needed to both improve our overall population’s health and improve the individual patient’s experience with the healthcare system.”

HBM Healthcare Investments has a track-record of over 100 biopharma and healthcare investments that have resulted in significant value creation by more than 50 trade sales and IPOs since inception.

“We look for companies that are at an advanced stage of development, that are closely tracked and actively guided on their strategic direction. We see a lot of potential in the BaseHealth model in addressing improvements in patient care and controlling costs in the healthcare system,” said Dr. Andreas Wicki, CEO, HBM Healthcare Investments.

About BaseHealth

BaseHealth is the comprehensive predictive analytics company for population health management. The company’s proprietary platform leverages machine learning to sift through millions of medical journals and patient records curated by scientists and physicians to offer healthcare providers the ability to identify patients with underlying risks for 43 chronic diseases and prevent costly treatments before they’re needed. At BaseHealth, we take the guesswork out of risk and population health management and put science in the driver’s seat.

BaseHealth was founded in 2011 by an interdisciplinary team of leading clinical geneticists, healthcare executives, software engineers, and physicians. Learn more at basehealth.com.

October 18, 2017 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Siemens Healthineers Supports Population Health Management with Planned Acquisition of Medicalis

  • Siemens Healthineers has signed an agreement to acquire Medicalis Corporation to expand Population Health Management portfolio
  • Medicalis’ expertise and solutions provide workflow orchestration and clinical decision support to health systems
  • Offerings expected to deliver desired service levels at lower costs while improving quality and productivity for healthcare providers

Siemens Healthineers plans to expand its Population Health Management (PHM) portfolio with the acquisition of Medicalis Corporation based in San Francisco and Kitchener, Ontario.  Medicalis is a leading provider of Clinical Decision Support (CDS) Solutions at the point of order entry, Imaging Workflow (IW) management, and Referral Management (RM). By incorporating these offerings into its PHM portfolio, Siemens Healthineers will enable healthcare providers to effectively bridge between PHM at the health system level and at the departmental level.  With an expanded focus on PHM, as well as a new name that underlines the company’s pioneering spirit and engineering expertise, Siemens Healthineers—the separately managed healthcare business of Siemens AG—is helping healthcare providers worldwide meet current challenges and excel in their respective environments.

“The mission of Siemens Healthineers is to be the trusted partner enabling health systems and healthcare providers worldwide to improve medical outcomes and reduce costs,” says Matthias Platsch, Head of Services, Siemens Healthineers. “The addition of Medicalis’ technology solutions to the Siemens Healthineers portfolio complements and supports our offerings in Population Health Management and Value-Based Healthcare, a key priority for our ongoing expansion through our Services business.”

The newly-acquired Population Health Management portfolio will extend the Siemens Healthineers strategy for Value-Based Healthcare across the health system enterprise and hospital departmental levels:

  • Clinical Decision Support provides the mechanism, as defined under the Protecting Access to Medicare Act of 2014 (PAMA), to check appropriateness of imaging orders and enables healthcare providers to define and evolve their standard of care, according to their appropriate use criteria (AUC), based on evidence and best practice. Today, 20%–30% of high-tech imaging procedures fail to provide information that improves patient welfare and, therefore, may represent, at least in part, unnecessary imaging services.
  • Imaging Workflow orchestrates the interpreting physician desktop, streamlining workflow, and standardization of diagnostic pathways for high-impact disease states. It ensures the right specialist, the right tools, a timely read, and prevention of care gaps.
  • Referral Management helps to avoid breaks in care by providing simple appointment scheduling tools, which help a patient schedule examinations in their network. This avoids leakage of patient information to another health system, which breaks communication and causes lost revenue.

In the short term, the solutions developed by Medicalis are expected to address the immediate need for consolidating providers to orchestrate and standardize their imaging workflow and to achieve compliance with the Protecting Access to Medicare Act of 2014, expected to become effective on January 1, 2018, which mandates consultation of appropriateness CDS at the point of order for certain advanced imaging tests. Siemens Healthineers believes these solutions will enable providers to achieve PAMA compliance while retaining control over the content, allowing them to move beyond simple compliance towards truly establishing an evolving standard of care based on evidence and direct health system experience.

“The acquisition of Medicalis will allow us to offer healthcare providers a powerful solution to define, implement, monitor, and evolve their own standard of care for their diagnostic service line,” says Robert Taylor, Head of Digital Services Population Health Management, Digital Health Services, Siemens Healthineers.  “We are excited to support our customers with these innovative tools to remove the variability from key high-impact disease states, to create standardized diagnostic pathways which enhance outcomes, control costs, and when combined with intelligent referral management, improve the patient experience overall.”

The solutions developed by Medicalis allow networks of hospitals (Health Systems/Integrated Delivery Networks) to improve physician productivity, manage patient referrals, and scheduling to enhance the relationship with the patient and ensure clinically appropriate imaging and tests to reduce inappropriate utilization.  Currently, seven of the top 25 Health Systems from Massachusetts to California use solutions developed by Medicalis to increase the quality of care they offer to patients.

“We are eager to be joining Siemens Healthineers and believe that this is a strong fit for our company because of our shared values and pioneering heritage,” says Oran Muduroglu, CEO of Medicalis Corporation. “With Siemens Healthineers, we will be able to broaden the context of our decision support, workflow, and referral management to utilize the full spectrum of diagnostic and therapeutic areas in which Siemens Healthineers operates, to address care gaps, streamline workflow, and help improve the overall experience of healthcare.”

The agreement to acquire the San Francisco, CA, USA and Kitchener, ON, Canada-based company by Siemens Healthineers was signed in April 2017.  Terms of the transaction are not disclosed.  The closing of the acquisition is subject to customary closing conditions.

 

Siemens Healthineers is the separately managed healthcare business of Siemens AG enabling healthcare providers worldwide to meet their current challenges and to excel in their respective environments. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. To help customers succeed in today’s dynamic healthcare marketplace, Siemens Healthineers is championing new business models that maximize opportunity and minimize risk for healthcare providers.

In fiscal 2016, which ended on September 30, 2016, Siemens Healthineers generated revenue of €13.5 billion and net income of over €2.3 billion and has about 46,000 employees worldwide. Further information is available at www.siemens.com/healthineers.

April 19, 2017 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

CareSkore Releases Industry’s First Population Health Management as a ServiceTM

PHMaaSTM Provides 3rd-party Apps Full Access to Complete Suite of Machine-learning Analytics through API

Mountain View, CA – February 9, 2017CareSkore, the leader in end-to-end personalized population health management, announced today the release of its Population Health Management as a ServiceTM (PHMaaSTM), providing direct access to its extensive machine-learning analytics engine to 3rd-party applications through an API.

“PHMaaS completely changes the game for how organizations adopt population health management,” said Jaspinder Grewal, CEO of CareSkore.  “We have too many proprietary application interfaces in health care.  PHMaaS allows us to provide insights within existing applications that are already part of user workflows.  Now patient-specific clinical, financial, and behavioral risk stratification is as simple as making a seamless API call from within your existing EHR and other applications.”

CareSkore’s personalized population health management SaaS platform incorporates advanced real-time analytics and innovative AI-based patient engagement to deliver optimized quality of care.  CareSkore PHMaaS provides existing health care IT systems seamless access to its machine-learning-based, real-time analytics engine, aptly called Zeus, through a simple API call.  Now EHRs, middleware platforms, enterprise data warehouses, clinical information networks, and health information exchanges that are already deployed can provide Zeus with real-time internal clinical and claims data and have Zeus augment that with external intelligence specific to every patient on things like demographics and socio-economic characteristics.  The output is patient-specific predictive analytics with a focus on how providers can quickly operationalize those insights. 

Traditional analytics typically achieve accuracy between 60 and 70%, while CareSkore can deliver greater than 90% accuracy to help create a full view of each patient.  This superior capability is driving rapid growth, with customers increasing 1,000% and headcount rising 12x in 2016.  By the end of 2017, CareSkore expects to be deployed in hundreds of locations.

“CareSkore has dramatically simplified the implementation of advanced patient-specific analytics,” said Rohit Arora, Professor and Chairman of Cardiovascular Medicine, Chicago Medical School.  “Access through and integration with existing EHR and other apps significantly lowers the barriers to adoption and deployment.”

CareSkore will exhibit at HIMSS 17 in Orlando in booth 1623 from February 20-22, 2017. To schedule a demo of the PHMaaS solution, go tohttp://resources.careskore.com/himss-2017.

About CareSkore

CareSkore is the leading provider of personalized population health management, leveraging machine-learning to generate real-time predictive and prescriptive analytics to understand each patient you are managing, what you are managing them for, and how you are/should be managing them.  CareSkore’s AI-enhanced post-discharged engagement reduces risk of patient behaviors that could lead to poorer outcomes.  CareSkore’s end-to-end patient care management platform ensures quality results and maximum revenue with value-based contracts.

February 9, 2017 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Amazing Charts Makes Five Predictions for Health IT in 2017

BOSTON, MA–(Marketwired – December 01, 2016) – Amazing Charts, LLC, a leading developer of Electronic Health Record (EHR) and Practice Management (PM) systems for physician practices, today issued five health IT predictions for 2017.

#1 Telemedicine will no longer be futuristic. Contrary to popular belief, telemedicine does not necessarily mean live video conferencing with a physician halfway across the country who lacks a full picture of the patient’s health status. Patients would rather receive “low tech” remote care from a local primary care physician they already know.

Telemedicine happens whenever an EHR system adds to a patient’s clinical chart the messages, pictures, or videos sent securely via smartphone. Use of smartphones for telemedicine will further increase with the introduction of add-on hardware for real-time collection of biometric data such as temperature, blood pressure and pulse.

This trend will be fueled by the expansion of reimbursement for non-face-to-face services. Medicare’s new billing code for Chronic Care Management is just one example of how the future of value-based care is not about 15-minute office visits, but instead keeping patients out of the office with follow-up phone calls about medications and answering patient questions via text.

#2 Practices will focus on reengineering patient access. As part of Medicare’s new Quality Payment Program, the Merit-based Incentive Payment System (MIPS) is designed to encourage providers to expand patient access with “practice improvement activities,” such as same-day appointments for urgent needs, longer office hours, and after-hours clinician advice.

Physicians also want to shift the responsibilities such as appointment scheduling from the office staff to the patient. Delegating that type of chore to the patient saves the staff time; and, patients not only don’t mind doing the work, they perceive value in self-service options that give them total control.

While tablet-based patient intake solutions have not become widespread because the hardware is costly and requires complex systems integration, simple web forms and PDF attachments can get the job done just as well.

#3 Physicians will get financially creative. A host of factors is pushing independent physicians to be more financially creative. These include the frustrations of making claims to insurance carriers, the new Medicare fee-for-value payments creating uncertainty in gauging reimbursement levels, and burnout with the “corporate medicine” model of seeing dozens of patients each day for lower fees.

One example of financial creativity is the direct care model which establishes a financial relationship between patient and provider, cutting out the middleman of insurance payers. This model includes concierge and direct primary care, where patients become members who pay a fixed monthly fee for unlimited care. There are also a growing number of cash-only practices for walk-in and urgent care.

Beleaguered small practices under financial stress are also looking for novel ways to generate cash. The new rules allowing reimbursement of telemedicine and other non-face-to-face services will encourage physicians to bill for activities they were already doing for free, such as phone calls with patients to discuss medications.

#4 Physicians will opt out of Medicare thanks to MACRA. Like all well-intentioned laws, The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) will have unintended consequences. Some providers in small independent practices will either opt-out of Medicare entirely, or decline to accept new Medicare patients if they currently fall below the threshold for exemption (less than $30,000 in Part B billings or 100 Part B patients).

To ease small practices into MACRA, the Final Rule issued by the Centers of Medicare & Medicaid Services (CMS) relaxed many of the requirements for 2017. By 2018, however, MACRA starts to impose more financial risk and stricter reporting requirements with less clarity around the return on investment. Small practices might just drop Medicare altogether and transition to a direct-care practice based on cash, membership, or a hybrid (see prediction #3 above).

#5 EHRs will become more interoperable. The next certification cycle from the Office of the National Coordinator for Health Information Technology (ONC) positions the EHR as a secure repository, allowing certified ancillary tools to be “snapped” into it. This will be driven by a new Application Programming Interface (API) called Fast Healthcare Interoperability Resources (FHIR). FHIR is a more granular way to exchange data without the rigid workflow of traditional Health Level Seven International (HL7).

Providers will benefit from the broader choice of technology solutions that can be used alongside the EHR to improve overall outcomes. Amazing Charts is currently developing a FHIR API to connect our EHR with other best-of-breed vendors for solutions such as population health management. This way small practices can leverage their investments in EHR systems to the maximum extent possible.

Furthermore, MIT researchers have proposed a cryptocurrency-backed system (like Bitcoin), called MedRec, for managing medical records that use the Ethereum blockchain. It is a novel, decentralized record management system for EHRs that uses blockchain technology to manage authentication, confidentiality, accountability, and data sharing.

About Amazing Charts

Amazing Charts provides Electronic Health Records (EHR/EMR), Practice Management, and other Health IT solutions to healthcare practices. Based on number one user ratings for usability, fair pricing, and overall satisfaction, Amazing Charts EHR has been adopted by more than 10,000 clinicians in over 7,100 private practices. Founded in 2001 by a family physician, today Amazing Charts, LLC operates as a subsidiary of Pri‐Med, an operating division of Diversified Communications (DC) and a trusted source for professional medical education to over 275,000 clinicians since 1995. Visit www.amazingcharts.com for more information.

Amazing Charts is a trademark of Amazing Charts, LLC. All products or service names mentioned herein are trademarks of their respective owners.

December 1, 2016 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Greenville Health System Selects Caradigm for Population Health

Caradigm Solutions to Play Critical Role in Greenville Health System’s Clinical Integration Efforts

BELLEVUE, WA – March 4, 2015 – Caradigm, the leader in enterprise population health, today announced that Greenville Health System (GHS) – the largest not-for-profit healthcare system in South Carolina – has selected Caradigm to help execute its population health strategy.

In developing its population health strategy, GHS recognized a need to standardize care models, risk stratification processes, and underlying data flow and analytics across its diverse system. The organization also understood that it would face a number of challenges, including disparate electronic medical record systems and health information exchanges. After an extensive evaluation, GHS concluded that Caradigm’s exclusive focus on population health and cloud-based delivery was best suited to meet its current and long-term needs for managing the clinical and financial risks of patient populations.

“Our goal is to improve care, reduce costs and enhance the patient experience across the entire continuum of care,” said Dr. Angelo Sinopoli, vice president of clinical integration and chief medical officer for GHS. “We believe that Caradigm has the right approach to population health, and by working together, we can achieve our goals more quickly.”

GHS will implement Caradigm’s Care Management, Quality Improvement and Risk Management solutions, as well as the Caradigm Intelligence Platform and Knowledge Hub. Through the implementation and use of these solutions, GHS will expand its insights to its patient populations by leveraging patient data stored in multiple, disparate systems across sites, with the ability to analyze, stratify and manage patient populations based on clinical outcomes and financial risk. Caradigm’s engagement with GHS will initially focus on patient population management for its participation in the Medicare Shared Savings Program and improved management of its self-insured employee and dependent lives.

“Caradigm is extremely impressed by the leadership position Greenville Health System is taking in population health and its commitment to achieving the highest levels of healthcare excellence while managing costs,” said Michael Simpson, CEO of Caradigm. “It is extremely gratifying to work with an organization like GHS, which recognizes that the shifts occurring in health care require new thinking and solutions to address a long-term strategy for population health.”

####

About Greenville Health System

Greenville Health System (GHS) — an academic health system that is the largest not-for-profit healthcare delivery system in South Carolina — is committed to medical excellence through research, patient care and education. GHS offers patients an innovative network of clinical integration, expertise and technologies through its eight medical campuses, tertiary medical center, research and education facilities, community hospitals, physician practices and numerous specialty services throughout the Upstate. The 1,358-bed system is home to 15 medical residency and fellowship programs. GHS is also home to the University of South Carolina School of Medicine Greenville, a joint effort of USC and GHS. To learn more, visit ghs.org.

About Caradigm (www.caradigm.com)

Caradigm is a population health company dedicated to helping organizations improve care, reduce costs, and manage risk. Caradigm analytics solutions provide insight into patients, populations, and performance, enabling healthcare organizations to understand their clinical and financial risk and identify the actions needed to address it. Caradigm population health solutions enable teams to deliver the appropriate care to patients through effective coordination and patient engagement, helping to improve outcomes and financial results. The key to Caradigm analytics and population health solutions is a rich set of clinical, operational, and financial data delivered to healthcare professionals within their workflows in real time. Visit: www.caradigm.com.

March 5, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.